Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence

Future Medicinal Chemistry

Volumn 5, Issue 11, 2013, Pages 1265-1284

  Worthington, Roberta J ^a   Blackledge, Meghan S ^a   Melander, Christian ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NEW DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ASSAY; BACTERIAL INFECTION; BACTERIUM; BIOFILM; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANT BACTERIA; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TWO-COMPONENT SYSTEM SIGNAL TRANSDUCTION PATHWAY; VIRULENCE;

BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BIOFILMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PROTEIN KINASES; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; VIRULENCE;

EID: 84892980568     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.58     Document Type: Review

References (131)

1. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerging Infectious Dis. 13(12), 1840-1846 (2007).
2. Boucher HW, Talbot GH, Bradley JS, et al.: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48(1), 1-12 (2009).
3. Payne DJ. Microbiology. Desperately seeking new antibiotics. Science 321(5896), 1644-1645 (2008).
4. Infectious Diseases Society of America. The 10 x ́20 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 50(8), 1081-1083 (2010).
5. Spellberg B, Guidos R, Gilbert D, et al.: The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin. Infect. Dis. 46(2), 155-164 (2008).
6. Spellberg B, Miller LG, Kuo MN, Bradley J, Scheld WM, Edwards Jr. JE. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Infection 35(3), 167-174 (2007).
7. Walker S, Chen L, Hu YN, Rew Y, Shin DW, Boger DL. Chemistry and biology of ramoplanin: A lipoglycodepsipeptide with potent antibiotic activity. Chem. Rev. 105(2), 449-475 (2005).
8. Laxminarayan R, Klein E, Smith DL. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13(12), 1840-1846 (2007).
9. Morell EA, Balkin DM. Methicillin-resistant Staphylococcus aureus: A pervasive pathogen highlights the need for new antimicrobial development. Yale J. Biol. Med. 83, 223-233 (2010).
10. Hogberg LD, Heddini A, Cars O. The global need for effective antibiotics: Challenges and recent advances. Trends Pharmocol. Sci. 31(11), 509-515 (2010).
11. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-A clinical super-challenge. N. Engl. J. Med. 360(5), 439-443 (2009).
12. Dolgin E. Sequencing of superbugs seen as key to combating their spread. Nat. Med. 16(10), 1054-1054 (2010).
13. Chopra I, Hesse L, O'Neill AJ. Exploiting current understanding of antibiotic action for discovery of new drugs. J. Appl. Microbiol. 92(Suppl), 4S-15S (2002).
14. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: A new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3(9), 541-548 (2007).
15. Mascher T, Helmann JD, Unden G. Stimulus perception in bacterial signal-Transducing histidine kinases. Microbiol. Mol. Biol. Rev. 70(4), 910-938 (2006).
16. Gooderham WJ, Hancock RE. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol. Rev. 33(2), 279-294 (2009).
17. Guarnieri M T, Zhang L, Shen J, Zhao R. The Hsp90 inhibitor radicicol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ. J. Mol. Biol. 379(1), 82-93 (2008).
18. Stock AM, Robinson VL, Goudreau PN. Two-component signal transduction. Annu. Rev. Biochem. 69, 183-215 (2000).
19. Walthers D, Tran VK, Kenney LJ. Interdomain linkers of homologous response regulators determine their mechanism of action. J. Bacteriol. 185(1), 317-324 (2003).
20. Belcheva A, Golemi-Kotra D. A close-up view of the VraSR two-component system. A mediator of Staphylococcus aureus response to cell wall damage. J. Biol. Chem. 283(18), 12354-12364 (2008).
21. Ray JC, Igoshin OA. Adaptable functionality of transcriptional feedback in bacterial two-component systems. PLoS Comput. Biol. 6(2), e1000676 (2010).
22. Gotoh Y, Eguchi Y, Watanabe T, Okamoto S, Doi A, Utsumi R. Two-component signal transduction as potential drug targets in pathogenic bacteria. Curr. Opin. Microbiol. 13(2), 232-239 (2010).
23. Szurmant H, Nelson K, Kim EJ, Perego M, Hoch JA.YycH regulates the activity of the essential YycFG two-component system in Bacillus subtilis. J. Bacteriol. 187(15), 5419-5426 (2005).
24. Biller SJ, Wayne KJ, Winkler M E, Burkholder WF. The putative hydrolase YycJ (WalJ) affects the coordination of cell division with DNA replication in Bacillus subtilis and may play a conserved role in cell wall metabolism. J. Bacteriol. 193(4), 896-908 (2011).
25. Qin Z, Zhang J, Xu B, et al.: Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol. 6, 96 (2006).
26. Garcia-Calderon CB, Casadesus J, Ramos-Morales F. Rcs and PhoPQ regulatory overlap in the control of Salmonella enterica virulence. J. Bacteriol. 189(18), 6635-6644 (2007).
27. Xue T, You Y, Hong D, Sun H, Sun B. The Staphylococcus aureus KdpDE two-component system couples extracellular K+ sensing and Agr signaling to infection programming. Infect. Immun. 79(6), 2154-2167 (2011).
28. Eguchi Y, Kubo N, Matsunaga H, Igarashi M, Utsumi R. Development of an antivirulence drug against Streptococcus mutans: Repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, walkmycin C. Antimicrob. Agents Chemother. 55(4), 1475-1484 (2011).
29. Stephenson K, Hoch JA. Virulence-And antibiotic resistance-Associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy. Pharmacol. Ther. 93(2-3), 293-305 (2002).
30. Poole K. Bacterial stress responses as determinants of antimicrobial resistance. J. Antimicrob. Chemother. 67(9), 2069-2089 (2012).
31. Groisman EA. The pleiotropic two-component regulatory system PhoP-PhoQ. J. Bacteriol. 183(6), 1835-1842 (2001).
32. Beceiro A, Llobet E, Aranda J, et al.: Phosphoethanolamine modification of lipid a in colistin-resistant variants of Acinetobacter baumannii mediated by the PmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55(7), 3370-3379 (2011).
33. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: Mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35(3), 219-226 (2010).
34. Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-Type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48(9), 3298-3304 (2004).
35. Hornsey M, Ellington MJ, Doumith M, et al.: AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J. Antimicrob. Chemother. 65(8), 1589-1593 (2010).
36. Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51(6), 2065-2069 (2007).
37. Mehta S, Cuirolo a X, Plata K B, et al.: VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 56(1), 92-102 (2012).
38. Jo DS, Montgomery CP, Yin S, Boyle-Vavra S, Daum RS. Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion. Antimicrob. Agents Chemother. 55(6), 2818-2823 (2011).
39. Matsuo M, Kato F, Oogai Y, Kawai T, Sugai M, Komatsuzawa H. Distinct two-component systems in methicillin-resistant Staphylococcus aureus can change the susceptibility to antimicrobial agents. J. Antimicrob. Chemother. 65(7), 1536-1537 (2010).
40. Kaczmarek FM, Dib-Hajj F, Shang WC, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob. Agents Chemother. 50(10), 3396-3406 (2006).
41. Srinivasan VB, Vaidyanathan V, Mondal A, Rajamohan G. Role of the two component signal transduction system CpxAR in conferring cefepime and chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044. PLoS ONE 7(4), e33777 (2012).
42. Hiron A, Falord M, Valle J, Debarbouille M, Msadek T. Bacitracin and nisin resistance in Staphylococcus aureus: A novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 81(3), 602-622 (2011).
43. Kolar SL, Nagarajan V, Oszmiana A, et al.: NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus. Microbiology 157(Pt 8), 2206-2219 (2011).
44. Macielag MJ, Goldschmidt R. Inhibitors of bacterial two-component signalling systems. Expert Opin. Invest. Drugs 9(10), 2351-2369 (2000).
45. Sperandio V, Torres a G, Kaper JB. Quorum sensing Escherichia coli regulators B and C (QseBC): A novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 43(3), 809-821 (2002).
46. Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. The QseC sensor kinase: A bacterial adrenergic receptor. Proc. Natl Acad. Sci. USA 103(27), 10420-10425 (2006).
47. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167-193 (2002).
48. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 4(3), 273-278 (2009).
49. Rogers SA, Huigens RW, Cavanagh J, Melander C. Synergistic effects between conventional antibiotics and 2-Aminoimidazole-derived antibiofilm agents. Antimicrob. Agents Chemother. 54(5), 2112-2118 (2010).
50. Davies D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2(2), 114-122 (2003).
51. Donlan RM. Biofilms: Microbial life on surfaces. Emerg. Infect. Dis. 8(9), 881-890 (2002).
52. Yang L, Liu Y, Wu H, et al.: Combating biofilms. FEMS Immunol. Med. Microbiol. 65(2), 146-157 (2011).
53. Richards JJ, Melander C. Controlling bacterial biofilms. Chem Bio Chem 10(14), 2287-2294 (2009).
54. Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology-Sgm 154, 3398-3409 (2008).
55. Petrova OE, Schurr JR, Schurr MJ, Sauer K. The novel Pseudomonas aeruginosa two-component regulator BfmR controls bacteriophage-mediated lysis and DNA release during biofilm development through PhdA. Mol. Microbiol. 81(3), 767-783 (2011).
56. Petrova OE, Sauer K. A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development. PLoS Pathog. 5(11), e1000668 (2009).
57. Parkins MD, Ceri H, Storey DG. Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation. Mol. Microbiol. 40(5), 1215-1226 (2001).
58. Vuong C, Saenz HL, Gotz F, Otto M. Impact of the AGR quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182(6), 1688-1693 (2000).
59. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4(4), e1000052 (2008).
60. Sharma-Kuinkel BK, Mann EE, Ahn JS, Kuechenmeister LJ, Dunman PM, Bayles KW. The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation. J. Bacteriol. 191(15), 4767-4775 (2009).
61. Okada A, Gotoh Y, Watanabe T, Furuta E, Yamamoto K, Utsumi R. Targeting two-component signal transduction: A novel drug discovery system. Methods Enzymol. 422, 386-395 (2007).
62. Matsushita M, Janda KD. Histidine kinases as targets for new antimicrobial agents. Bioorg. Med. Chem. 10(4), 855-867 (2002).
63. Schreiber M, Res I, Matter A. Protein kinases as antibacterial targets. Curr. Opin. Cell. Biol. 21(2), 325-330 (2009).
64. Watanabe T, Okada A, Gotoh Y, Utsumi R. Inhibitors targeting two-component signal transduction. Adv. Exp. Med. Biol. 631, 229-236 (2008).
65. Furuta E, Yamamoto K, Tatebe D, Watabe K, Kitayama T, Utsumi R. Targeting protein homodimerization: A novel drug discovery system. FEBS Lett. 579(10), 2065-2070 (2005).
66. Matsushita M, Janda KD. Histidine kinases as targets for new antimicrobial agents. Bioorg. Med. Chem. 10(4), 855-867 (2002).
67. Barrett JF, Goldschmidt RM, Lawrence LE, et al.: Antibacterial agents that inhibit two-component signal transduction systems. Proc. Natl Acad. Sci. USA 95(9), 5317-5322 (1998).
68. Stephenson K, Yamaguchi Y, Hoch JA. The mechanism of action of inhibitors of bacterial two-component signal transduction systems. J. Biol. Chem. 275(49), 38900-38904 (2000).
69. Macielag MJ, Goldschmidt R. Inhibitors of bacterial two-component signalling systems. Expert Opin. Investig. Drugs 9(10), 2351-2369 (2000).
70. Hilliard JJ, Goldschmidt RM, Licata L, Baum EZ, Bush K. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob. Agents Chemother. 43(7), 1693-1699 (1999).
71. Roychoudhury S, Zielinski NA, Ninfa AJ, et al.: Inhibitors of two-component signal transduction systems: Inhibition of alginate gene activation in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 90(3), 965-969 (1993).
72. Yamamoto K, Kitayama T, Ishida N, et al.: Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. Biosci. Biotechnol. Biochem. 64(4), 919-923 (2000).
73. Yamamoto K, Kitayama T, Minagawa S, et al.: Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci. Biotechnol. Biochem. 65(10), 2306-2310 (2001).
74. Gilmour R, Foster JE, Sheng Q, et al.: New class of competitive inhibitor of bacterial histidine kinases. J. Bacteriol 187(23), 8196-8200 (2005).
75. Watanabe T, Igarashi M, Okajima T, et al.: Isolation and characterization of signermycin B, an antibiotic that targets the dimerization domain of histidine kinase WalK. Antimicrob. Agents Chemother. 56(7), 3657-3663 (2012).
76. Okada A, Igarashi M, Okajima T, et al.: Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth. J. Antibiot. (Tokyo) 63(2), 89-94 (2010).
77. Qi F, Merritt J, Lux R, Shi W. Inactivation of the ciaH Gene in Streptococcus mutans diminishes mutacin production and competence development, alters sucrose-dependent biofilm formation, and reduces stress tolerance. Infect. Immun. 72(8), 4895-4899 (2004).
78. Zhang J, Biswas I. A phenotypic microarray analysis of a Streptococcus mutans liaS mutant. Microbiology 155(Pt 1), 61-68 (2009).
79. Reck M, Rutz K, Kunze B, et al.: The biofilm inhibitor carolacton disturbs membrane integrity and cell division of Streptococcus mutans through the serine/threonine protein kinase PknB. J. Bacteriol. 193(20), 5692-5706 (2011).
80. Qin Z, Lee B, Yang L, et al.: Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms. FEMS Microbiol. Lett. 273(2), 149-156 (2007).
81. Dubrac S, Boneca I G, Poupel O, Msadek T. New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. J. Bacteriol. 189(22), 8257-8269 (2007).
82. Rasko DA, Moreira CG, Li De R, et al.: Targeting QseC signaling and virulence for antibiotic development. Science 321(5892), 1078-1080 (2008).
83. Winkler ME, Hoch JA. Essentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in gram-positive bacteria. J. Bacteriol. 190(8), 2645-2648 (2008).
84. Ulijasz a T, Weisblum B. Dissecting the VanRS signal transduction pathway with specific inhibitors. J. Bacteriol. 181(2), 627-631 (1999).
85. Worthington RJ, Richards JJ, Melander C. Small molecule control of bacterial biofilms. Org. Biomol. Chem. 10(37), 7457-7474.
86. Harris TL, Worthington RJ, Melander C. Potent small-molecule suppression of oxacillin resistance in methicillin-resistant Staphylococcus aureus. Angew. Chem. Int. Ed. Engl. 51(45), 11254-11257 (2012).
87. Rogers SA, Huigens RW, Cavanagh J, Melander C. Synergistic effects between conventional antibiotics and 2-Aminoimidazole-derived antibiofilm agents. Antimicrob. Agents Chemother. 54(5) 2112-2118 (2010).
88. Worthington RJ, Bunders CA, Reed CS, Melander C. Small molecule suppression of carbapenem resistance in NDM-1 producing Klebsiella pneumoniae. ACS Med. Chem. Lett. 3(5), 357-361 (2012).
89. Ballard TE, Richards JJ, Wolfe AL, Melander C. Synthesis and antibiofilm activity of a second-generation reverse-Amide oroidin library: A structure-Activity relationship study. Chem. Eur. J. 14(34), 10745-10761 (2008).
90. Thompson R J, Bobay B G, Stowe S D, et al.: Identification of BfmR, a response regulator involved in biofilm development, as a target for a 2-Aminoimidazole-based antibiofilm agent. Biochemistry 51(49), 9776-9778 (2012).
91. Klitgaard JK, Skov MN, Kallipolitis BH, Kolmos HJ. Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J. Antimicrob. Chemother. 62(6), 1215-1221 (2008).
92. Bonde M, Hojland DH, Kolmos HJ, Kallipolitis BH, Klitgaard JK. Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 318(2), 168-176 (2011).
93. Tang YT, Gao R, Havranek JJ, Groisman EA, Stock AM, Marshall GR. Inhibition of bacterial virulence: Drug-like molecules targeting the Salmonella enterica PhoP response regulator. Chem. Biol. Drug Des. 79(6), 1007-1017 (2012).
94. Igo MM, Ninfa AJ, Stock JB, Silhavy TJ. Phosphorylation and dephosphorylation of a bacterial transcriptional activator by a transmembrane receptor. Genes Dev. 3(11), 1725-1734 (1989).
95. Filippou PS, Lioliou EE, Panagiotidis CA, et al.: Effect of polyamines and synthetic polyamine-Analogues on the expression of antizyme (AtoC) and its regulatory genes. BMC Biochem. 8, 1 (2007).
96. Ogura M, Shimane K, Asai K, Ogasawara N, Tanaka T. Binding of response regulator DegU to the aprE promoter is inhibited by RapG, which is counteracted by extracellular PhrG in Bacillus subtilis. Mol. Microbiol. 49(6), 1685-1697 (2003).
97. Ewann F, Locht C, Supply P. Intracellular autoregulation of the Mycobacterium tuberculosis PrrA response regulator. Microbiology 150(Pt 1), 241-246 (2004).
98. Burdman S, Shen Y, Lee S W, Xue Q, Ronald P. RaxH/RaxR: A two-component regulatory system in Xanthomonas oryzae pv. oryzae required for AvrXa21 activity. Mol. Plant Microbe. Interact. 17(6), 602-612 (2004).
99. Mandin P, Fsihi H, Dussurget O, et al.: VirR, a response regulator critical for Listeria monocytogenes virulence. Mol. Microbiol. 57(5), 1367-1380 (2005).
100. Anetzberger C, Reiger M, Fekete A, et al.: Autoinducers act as biological timers in Vibrio harveyi. PLoS ONE 7(10), e48310 (2012).
101. Anetzberger C, Schell U, Jung K. Single cell analysis of Vibrio harveyi uncovers functional heterogeneity in response to quorum sensing signals. BMC Microbiol. 12, 209 (2012).
102. Macielag MJ, Demers JP, Fraga-Spano SA, et al.: Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria. J. Med. Chem. 41(16), 2939-2945 (1998).
103. Dengler V, Meier P S, Heusser R, Berger-Bachi B, Mccallum N. Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. BMC Microbiol. 11, 16 (2011).
104. Leday TV, Gold KM, Kinkel TL, Roberts SA, Scott JR, Mciver KS. TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus. Infect. Immun. 76(10), 4659-4668 (2008).
105. Furuta E, Yamamoto K, Tatebe D, Watabe K, Kitayama T, Utsumi R. Targeting protein homodimerization: A novel drug discovery system. FEBS Lett. 579(10), 2065-2070 (2005).
106. Okada A, Gotoh Y, Watanabe T, Furuta E, Yamamoto K, Utsumi R. Targeting two-component signal transduction: A novel drug discovery system. Methods Enzymol. 422, 386-395 (2007).
107. Wilke KE, Francis S, Carlson EE. Activity-based probe for histidine kinase signaling. J. Am. Chem. Soc. 134(22), 9150-9153 (2012).
108. Carlson HK, Plate L, Price MS, Allen JJ, Shokat KM, Marletta MA. Use of a semisynthetic epitope to probe histidine kinase activity and regulation. Anal. Biochem. 397(2), 139-143 (2010).
109. Barbieri CM, Stock AM. Universally applicable methods for monitoring response regulator aspartate phosphorylation both in vitro and in vivo using Phos-Tag-based reagents. Anal. Biochem. 376(1), 73-82 (2008).
110. Scharf BE. Summary of useful methods for two-component system research. Curr. Opin. Microbiol. 13(2), 246-252 (2010).
111. Lukat GS, Mccleary WR, Stock AM, Stock JB. Phosphorylation of bacterial response regulator proteins by low molecular weight phospho-donors. Proc. Natl Acad. Sci. USA 89(2), 718-722 (1992).
112. Feng J, Atkinson MR, Mccleary W, Stock JB, Wanner BL, Ninfa AJ. Role of phosphorylated metabolic intermediates in the regulation of glutamine synthetase synthesis in Escherichia coli. J. Bacteriol. 174(19), 6061-6070 (1992).
113. Yan D, Cho HS, Hastings CA, et al.: Beryllofluoride mimics phosphorylation of NtrC and other bacterial response regulators. Proc. Natl Acad. Sci. USA 96(26), 14789-14794 (1999).
114. Gao R, Tao Y, Stock a M. System-level mapping of Escherichia coli response regulator dimerization with FRET hybrids. Mol. Microbiol. 69(6), 1358-1372 (2008).
115. King S T, Kenney LJ. Application of fluorescence resonance energy transfer to examine EnvZ/OmpR interactions. Methods Enzymol. 422, 352-360 (2007).
116. Sciara MI, Spagnuolo C, Jares-Erijman E, Garcia Véscovi E. Cytolocalization of the PhoP response regulator in Salmonella enterica: Modulation by extracellular Mg2+ and by the SCV environment. Mol. Microbiol. 70(2), 479-493 (2008).
117. Ulijasz a T, Kay BK, Weisblum B. Peptide analogues of the VanS catalytic center inhibit VanR binding to its cognate promoter. Biochemistry 39(37), 11417-11424 (2000).
118. Erickson MG, Ulijasz a T, Weisblum B. Bacterial 2-component signal transduction systems: A fluorescence polarization screen for response regulator-protein binding. J. Biomol. Screen. 10(3), 270-274 (2005).
119. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (Agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect. Immun. 61(9), 3879-3885 (1993).
120. Novick RP, Projan SJ, Kornblum J, et al.: The Agr P2 operon: An autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248(4), 446-458 (1995).
121. Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect. Immun. 68(3), 1048-1053 (2000).
122. Roychoudhury S, Sakai K, Chakrabarty AM. AlgR2 is an ATP/GTP-dependent protein kinase involved in alginate synthesis by Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 89(7), 2659-2663 (1992).
123. Sertoli MR, Bruzzi P, Pronzato P, et al.: Randomized cooperative study of perioperative chemotherapy in breast cancer. J. Clin. Oncol. 13(11), 2712-2721 (1995).
124. Schlictman D, Kubo M, Shankar S, Chakrabarty AM. Regulation of nucleoside diphosphate kinase and secretable virulence factors in Pseudomonas aeruginosa: Roles of algR2 and algH. J. Bacteriol. 177(9), 2469-2474 (1995).
125. Tomaras a P, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 154(Pt 11), 3398-3409 (2008).
126. Foynes S, Dorrell N, Ward SJ, et al.: Helicobacter pylori possesses two CheY response regulators and a histidine kinase sensor, CheA, which are essential for chemotaxis and colonization of the gastric mucosa. Infect. Immun. 68(4), 2016-2023 (2000).
127. Qin X, Singh KV, Weinstock GM, Murray BE. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68(5), 2579-2586 (2000).
128. Pickard D, Li J, Roberts M, et al.: Characterization of defined ompR mutants of Salmonella typhi: OmpR is involved in the regulation of Vi polysaccharide expression. Infect. Immun. 62(9), 3984-3993 (1994).
129. Lindgren SW, Stojiljkovic I, Heffron F. Macrophage killing is an essential virulence mechanism of Salmonella typhimurium. Proc. Natl Acad. Sci. USA 93(9), 4197-4201 (1996).
130. Worley MJ, Ching KH, Heffron F. Salmonella SsrB activates a global regulon of horizontally acquired genes. Mol. Microbiol. 36(3), 749-761 (2000).
131. Oyston PC, Dorrell N, Williams K, et al.: The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect. Immun. 68(6), 3419-3425 (2000).